(Q70229768)

English

The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients

scientific article published on 01 January 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

R J North

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

69-74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00205736

0 references

Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which T cells cause graft rejection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

?-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional activity in vivo of effector T cell populations. I. Antitumor activity exhibited by allogeneic mixed leukocyte culture cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymus-dependent response: too little and too late for immunosurveillance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of antitumor immunity ? Immunobiologic approaches

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6334549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00205736

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334549%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70229768&oldid=1643513125"